Prevalence of prediabetes and associated factors in southwest iran: results from Hoveyzeh cohort study

BMC Endocrine Disorders

Table 4 The association of biochemical and clinical parameters with prevalence of prediabetes based on the adjusted analyses—logistic regression model among participants: The Hoveyzeh Cohort Study

Variables	Male		Female		Total
Variables	▀Adjusted OR (95%CI)	P	▀Adjusted OR (95%CI)	p	▀Adjusted OR (95%CI)	P
Triglyceride (mg/dl) (≤ 150 mg/dl)
150-199 mg/dl	1.06 (0.85,1.33)	0.6	1.32(1.11,1.58)	0.002	1.32(1.16,1.51)	< 0.001
≥ 200 mg/dl	1.36 (1.11,1.67)	0.03	1.73(1.44,2.07)	< 0.001	1.64(1.44,1.86)	< 0.001
Cholesterol (≤ 200 mg/dl)
200–239 mg/dl	1.18(1.01,1.44)	< 0.001	1.18 (1.01,1.38)	0.042	1.33 (1.18,1.49)	< 0.001
≥ 240 mg/dl	2 (1.5, 2.68)	< 0.001	1.53 (1.22,1.91)	< 0.001	2.04 (1.72,2.42)	< 0.001
HDL-C (Normal)*
Abnormal*	0.91 (0.75,1.105)	0.35	1.035 (0.9,1.19)	0.63	1.04(0.93,1.16)	0.47
Systolic Blood Pressure (≤ 140 mmHg)
≥ 140 mmHg	1.48 (1.11,1.98)	0.008	1.39 (1.07,1.82)	0.014	1.95(1.62,2.35)	< 0.001
Diastolic Blood Pressure (≤ 90 mmHg)
≥ 90 mmHg	1.14 (0.84,1.55)	0.38	1.31 (0.98,1.76)	0.011	1.54(1.26,1.89)	< 0.001
GOT	1.016 (1.007,1.026)	0.001	1.012 (1.003,1.02)	0.005	1.013 (1.007,1.019)	0.001
GPT	1.009 (1.005,1.014)	< 0.001	1.012 (1.006,1.017)	< 0.001	1.01 (1.006,1.013)	< 0.001

HDL-C High-density Lipoprotein Cholesterol, GOT Glutamic Oxaloacetic transaminase, GPT Glutamic pyruvic transaminase
^*For male: HDL-C < 40 mg/dl, for women < 50 mg/dl
Normal HDL-C is defined as HDL-C ≥ 40 (in men) and ≥ 50 mg/dl (in women)
OR Odds ratio, CI Confidence Interval
P-value < 0.05 was considered significant
^▀Adjusted for all variables in Table 3 (age real, Marital status, wealth scores, smoking cigarette, Alcohol drinker, history of CI, MI, and stroke, Body Mass Index, PA, and daily energy intake)

ISSN: 1472-6823